Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 40,000 shares at $97.32 ($3.8M) on 2020-04-24, disclosed to the SEC on 2020-04-28.
Seasonal sale ($3.8M) by President, Worldwide R&D — this insider has traded BMRN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.34 | 13,642 | $1.3M | 33.9% |
| 2 | $95.34 | 13,642 | $1.3M | 33.9% |
| 3 | $96.85 | 3,678 | $356K | 9.3% |
| 4 | $96.85 | 3,678 | $356K | 9.3% |
| 5 | $97.32 | 2,680 | $261K | 6.8% |
| 6 | $97.32 | 2,680 |
| $261K |
| 6.8% |
| Total | $95.88 avg | 40,000 | $3.8M | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |